NOCIL vs STYRENIX: Stock Comparison

NOCIL vs STYRENIX PERFORMANCEUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

STYRENIX PERFORMANCE is the larger company by market capitalisation. NOCIL shows faster revenue growth and lower leverage, while STYRENIX PERFORMANCE shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NOCIL leads 4; STYRENIX leads 9 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NOCILSTYRENIX

Valuation lens

What price are you paying?

Market CapContext only
₹3,163 Cr
₹3,708 Cr
P/E RatioSTYRENIX has the lower reading
47.82x
13.59x
P/B RatioNOCIL has the lower reading
1.78x
2.71x
EPSSTYRENIX has the higher reading
₹1.64
₹78.09
Book ValueContext only
₹106.18
₹776.95
Dividend YieldSTYRENIX has the higher reading
0.79%
2.18%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
STYRENIX is the larger company
₹3,708 Cr vs ₹3,163 Cr
P/E Ratio
STYRENIX has a lower P/E
13.59x vs 47.82x
P/B Ratio
NOCIL has a lower P/B
1.78x vs 2.71x
EPS
STYRENIX has higher earnings per share
₹78.09 vs ₹1.64
Dividend Yield
STYRENIX has a higher dividend yield
2.18% vs 0.79%
Revenue Growth (TTM YoY)
NOCIL has faster revenue growth
-2.8% vs -12.1%
EPS Growth (TTM YoY)
STYRENIX has faster EPS growth
30.9% vs -19.2%
Qtr Sales Growth
NOCIL has stronger quarterly sales growth
0% vs -24.02%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNOCILSTYRENIX
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricNOCILSTYRENIX
Live Price₹189.65₹2,113.1
Day Change-2.9%-1.39%
Volume12.03 L34,221
52-Week High₹204.5₹2,653.8
52-Week Low₹125.31₹1,780
Distance from 52W High-7.26%-20.37%

Valuation

MetricNOCILSTYRENIX
Market Cap₹3,163 Cr₹3,708 Cr
P/E Ratio47.82x13.59x
P/B Ratio1.78x2.71x
EPS₹1.64₹78.09
Book Value₹106.18₹776.95
Dividend Yield0.79%2.18%

Growth

MetricNOCILSTYRENIX
Revenue Growth (TTM YoY)-2.8%-12.1%
EPS Growth (TTM YoY)-19.2%30.9%
Qtr Sales Growth0%-24.02%
Qtr Profit Growth-1.59%-0.71%

Profitability & Leverage

MetricNOCILSTYRENIX
ROE3.61%13.38%
ROCE4.04%12.38%
Net Margin4.86%5.42%
Operating Margin6.54%7.06%
Debt to Equity0x0.23x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNOCILSTYRENIX
Promoter Holding33.76%46.24%
FII Holding4.78% 0.23 pp0.86% 0.09 pp
DII Holding7.47% 0.44 pp17.44% 0.11 pp
Public Holding53.98% 0.2 pp35.46% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NOCIL and STYRENIX PERFORMANCE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.